Beijing Suncadia Pharmaceuticals Co., Ltd

This study tested a new injectable drug, SHR-1918, added to standard cholesterol-lowering medications (statins) in 335 adults whose cholesterol remained high despite treatment. The main goal was to see how much it lowered 'bad' LDL cholesterol after 16 weeks. The study is complet…

This study tested a new medicine called SHR-1918, given as multiple shots under the skin, in 44 adults with high cholesterol that was not well controlled by current treatments. The goal was to see if it safely lowers "bad" LDL cholesterol more than a placebo over 24 weeks. Partic…

This study tested a new medicine called SHR-1918 in 55 people with homozygous familial hypercholesterolemia (HoFH), a rare genetic condition that causes extremely high cholesterol and early heart disease. Participants received either the drug or a placebo, and researchers measure…

This study tested a new medicine called SHR-1918 in 26 adults with homozygous familial hypercholesterolemia (HoFH), a rare genetic condition causing extremely high cholesterol. The goal was to see if the drug could safely lower their LDL (bad) cholesterol after 12 weeks. Particip…

This study tested a new medicine called SHR-2004 to prevent blood clots in people having knee replacement surgery. About 1,166 adults took part. The goal was to see if the injection works better than standard care at stopping dangerous clots without causing serious bleeding.

This early-stage study tested the safety and how the body processes a new drug called HRS-8829 in 83 healthy adults aged 18 to 55. Participants received either the drug or a placebo in increasing doses, and researchers monitored side effects and drug levels in the blood. The goal…